Senti Biosciences Inc (SNTI)
NASDAQHealth CareBiotechnologySnapshot 2026-11-05
$0.16-6.85%
Close 2026-11-05 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-11-05
QuarterlyIQ Insights · SNTI
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance is holding in the top half of its industry — the reason to own it looks intact.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | 322.7% |
| Our one-year growth estimate | diamond | Not available |
Growth built into the price is above our model estimate.
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
Usually moved in the same direction.
Price observations: 365 days
Most sensitive to the broad stock market.
Based on historical daily prices through 2026-11-05.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
A comparable growth gap is not available.
The one-year revenue growth assumption on Valuation.
Elevated risk of a next-quarter earnings miss: this name is a smaller-cap name (higher miss base rate) and operates in a high-miss-rate industry. A fundamental tilt, not a price call.
Model as of 2026-11-05 · Compared with 117 industry peers
SNTI — dividend update
Dated 2026-10-26
Entry into a Material Definitive Agreement. CVR Agreement On October 21, 2026 (the “Closing Date”), in connection with the closing (the “Closing”) of the transactions contemplated by the Merger Agreement, Midco entered into a Contingent Value Rights Agreement, dated as of October 21, 2026 (the “CVR Agreement”), by and between Midco and Continental Stock Transfer & Trust Company, as rights agent (the “Rights Agent”). The CVR Agreement governs the terms of the CVRs issued in connection with the…
Why it matters: The company reported $3.1 million in pro forma cash at June 30. The report can show whether new funding covers work on its retained programs.
Worry ifThe Nov. 12 report gives a cash balance above $3.1 million and names funds available for Rett syndrome or TIL work.
Less concerning ifThe report shows cash below $3.1 million and no new funds for Rett syndrome or TIL work.
Why it matters: The company required note holders to exchange debt for shares at $0.342 per share. The final share count can show the size of dilution.
Worry ifA filing confirms the exchange issued shares. It states the total number of new shares and the resulting share count.
Less concerning ifA filing says the exchange did not occur or that note holders received no shares.
Why it matters: These are the programs SNTI kept after the deal. A dated study or lab milestone would show progress on its new focus.
Supportive ifSNTI reports a dated Rett syndrome or TIL milestone, such as starting a study or naming a first patient treated.
Worry ifThe next earnings report gives no dated Rett syndrome or TIL milestone, or reports a pause in either program.
Why it matters: Nasdaq notified SNTI that its bid price stayed below the minimum for 30 straight trading days. A cure can keep the listing in good standing.
Worry ifNasdaq confirms SNTI closed at or above the minimum bid price for the required period. SNTI regained compliance.
Less concerning ifNasdaq sets a delisting date or says SNTI failed to regain the minimum bid price.
We watch for confirming and disproving signals on each item. Resolutions are found automatically where possible and checked by hand for unclear cases. Last 90 days shown.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$370 on $10,000 · ±3.7% | How much price usually moves either way. |
| Bad day | $1,043 loss on $10,000 · 10.4% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $9,312 loss on $10,000 · 93.1% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.